FDA warning letter · Medical Devices

Shenzhen Sunell Technology Corporation

Issued · Posted by FDA

FDA published a close-out letter on Jul 27, 2023. The passages below are from the original warning letter.

Selected passages from the FDA letter

Quoted FDA text from the published dataset. These selected excerpts are not the complete letter.

Passage 1

At the start-up of 2020, Covid-19 had been sweeping through the mainland of China, and now is getting threatening worldwide. From the occurrence of the epidemic to today, Sunell's ''panda camera'' -- Body Temperature Measurement System played an important role in the work of prevention and control of epidemic. It has become the guardians for thousands of prevention and control site and points worldwide.

Passage 2

FIGHTING CORONAVIRUS WE ARE AT THE FRONTIER!

Passage 3

The Screening Cameras are offered for sale in the United States without marketing approval, clearance, or authorization from FDA.

Passage 4

your products are adulterated under section 501(f)(1)(B) of the Act, 21 U.S.C. § 351(f)(1)(B), because your firm does not have approved applications for premarket approval (PMA) in effect pursuant to section 515(a) of the Act, 21 U.S.C. § 360e(a), or approved applications for an investigational device exemption (IDE) under section 520(g) of the Act, 21 U.S.C. § 360j(g).

Passage 5

Your products are also misbranded under section 502(o) the Act, 21 U.S.C. § 352(o), because your firm did not notify the agency of its intent to introduce these products into interstate commerce for commercial distribution as required by section 510(k) of the Act, 21 U.S.C. § 360(k).